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Background: The widespread use of phthalates as plasticizers has raised public health concerns regarding their
adverse effects, including an association with cancer. Although animal investigations have suggested an association
between phthalate exposure and hepatocellular carcinoma, the mechanisms are unknown.
Methods: The hepatocellular carcinoma cell line Huh7 was treated with benzyl butyl phthalate (BBP), and then analyzed
by total internal reflection fluorescence microscopy, confocal microscopy and double immunogold transmission electron
microscopy. Following BBP treatment, mRNA levels were measured by RT-PCR, protein levels were measured using
western blot, and vascular endothelial growth factor levels were measured by an enzyme-linked immunosorbent
assay. Cell migration and invasion assays were evaluated by transwell, and angiogenesis were performed by a tube
formation assay. Nude mice were used to investigate metastasis and angiogenesis in vivo.
Results: BBP affected hepatocellular carcinoma progression through the aryl hydrocarbon receptor (AhR) and that
benzyl butyl phthalate (BBP) stimulated AhR at the cell surface, which then interacted with G proteins and triggered
a downstream signaling cascade. BBP activated AhR through a nongenomic action involving G-protein signaling rather
than the classical genomic AhR action. BBP treatment promoted cell migration and invasion in vitro and metastasis
in vivo via the AhR/Gβ/PI3K/Akt/NF-κB pathway. In addition, BBP induced both in vitro and in vivo angiogenesis through
the AhR/ERK/VEGF pathway.
Conclusions: These findings suggest a novel nongenomic AhR mechanism involving G-protein signaling induced by
phthalates, which contributes to tumor progression of hepatocellular carcinoma.
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Globally, hepatocellular carcinoma is the sixth most
common cancer and the third most common cause of
cancer-related deaths [1]. Risk factors for hepatocellular
carcinoma include infection with hepatitis B or C viruses,
alcohol consumption, smoking, and environmental factors* Correspondence: tsaieing@yahoo.com; kuopolin@seed.net.tw
†Equal contributors
1Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical
University, Kaohsiung City 807, Taiwan
9Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical
University, No. 100, Zihyou 1st Rd., Sanmin District, Kaohsiung, Taiwan
Full list of author information is available at the end of the article
© 2014 Tsai et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.[2]. Oral administration of phthalates to rats results in liver
enlargement and cause increased malondialdehyde levels
in the liver, indicating that phthalates cause oxidative
damage of the liver [3]. Bis(2-ethylhexyl) phthalate (DEHP)
acts as a promoter of hepatocellular tumors initiated
by N-nitrosodiethylamine [4]. Moreover, lifetime DEHP
treatment induces testis and liver cancer in rats [5]. Based
on proteomic analysis, the proteins secreted by HepG2
cells that have been treated with benzyl butyl phthalate
(BBP) are associated with DNA damage, tumor progres-
sion, apoptosis, energy metabolism, and cell structure and
motility [6]. The observed roles of BBP in DNA damage. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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proliferation suggest the involvement of BBP in tumor de-
velopment and progression. These findings support car-
cinogenesis induced by phthalates, but the mechanism
remains largely unknown.
Previous studies have shown that phthalates affect the
activation of the aryl hydrocarbon receptor (AhR) [7,8].
Moreover, phthalates suppressed type I interferon ex-
pression in human plasmacytoid dendritic cells via AhR
[9]. Our previous study showed that BBP induces necro-
sis in human granulosa cells via AhR activation followed
by downstream CYP1B1 induction [10]. We also showed
that phthalates induce proliferation and invasiveness of
breast cancer through the AhR/HDAC6/c-Myc signaling
pathway [11]. These results suggest that AhR is an im-
portant receptor that mediates multiple biological effects
of phthalates.
The ligand-activated transcriptional factor AhR regu-
lates the enzymatic functions needed for xenobiotic me-
tabolism. Previous reports revealed two pathways that
mediate AhR effects including genomic and non-genomic
pathways. The classical genomic function involves AhR nu-
clear translocation and binding to xenobiotic responsive el-
ements located in the promoters of target genes, CYP1A1
and CYP1B1 [12]. In addition to the classical genomic
AhR function, AhR can regulate gene expression through a
nongenomic mechanism. The Study of nongenomic signal-
ing is important in the field of toxicology. It is difficult to
identify dioxin response element (DRE)-based target genes
and many reports suggest that the toxic effect of 2, 3, 7,
8-tetrachlorodibenzo-p-dioxin (TCDD) is more compat-
ible with the nongenomic signaling of AhR, rather than
the genomic action [13]. Moreover, our previous study
reported a phthalate mediated AhR/HDAC6/c-Myc path-
way that demonstrated a nongenomic effect of AhR [10].
Several studies have reported that TCDD induces inflam-
matory responses through a nongenomic AhR function
[14-17], although this nongenomic AhR function remains
poorly understood.
Here, we found that BBP promotes angiogenesis, mi-
gration and invasion in vitro as well as angiogenesis and
metastasis in vivo of hepatocellular carcinoma. Because
G-protein signaling is involved in the regulation of AhR
stability [18], we further investigated the AhR function
and its possible relationship to G-protein signaling in
hepatocellular carcinoma.
Additionally, we revealed that the mechanism through
which phthalates activate the nongenomic AhR pathway
is associated with G-protein signaling.
Methods
Chemicals and plasmid
Fluo-4 was purchased from Invitrogen (Carlsbad, CA,
USA). BBP, 2-aminoethoxydiphenyl borate (2-APB), and6-diamidino-2-phenylindole (DAPI) were purchased
from Sigma-Aldrich Co. (St. Louis, MO, USA). Pd98059
and wortmannin were obtained from Calbiochem-
Novabiochem (San Diego, CA, USA).
pEGFP-C1-AhR, a kind gift from Dr. Hsin-yu Lee
(Department of Life Science, National Taiwan University),
was cloned the AhR gene into pEGFP-C1 (Clontech).
Cell culture
Huh7 cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) (Life Technologies, Grand Island, NY,
USA), PLC/PRF/5 and HepG2 cells were cultured in
minimum essential medium (MEM) (Life Technologies,
Grand Island, NY, USA) and supplemented with 10% fetal
bovine serum (Gibco, California,CA, USA), 1% penicillin
(100 U/mL), streptomycin (10 μg/mL), and amphotericin-
B (250 μg/mL) (Sigma-Aldrich Co, St. Louis, MO). Human
umbilical vein endothelial cells (HUVEC) were grown in
EGM-2 medium (Lonza, Basel, Switzerland). All cells were
cultured at 37°C in 5% CO2.
Total internal reflection fluorescennce microscopy
For total internal reflection fluorescennce (TIRF) micros-
copy studies, Huh7 cells were transfected with pEGFP-
C1-AhR or pEGFP-C1 as a control using LT1 transfection
reagent (Mirus, Madison, WI, USA). After transfection for
24 hours, the cells were harvested and cultured on cover-
slips for 1 day. Cells were then treated with DMSO as a
control or BBP (1 μΜ) and analyzed by TIRF microscopy
(Carl Zeiss, Oberkochen, Germany). GFP intensity was
analyzed by Axio Vision Rel. 4.8 software (Carl Zeiss,
Oberkochen, Germany).
Calcium imaging
Calcium imaging was performed using the same method
as in a previous study [19] with some modifications.
For live cell calcium imaging, Cell-R software was used
for microscopy (Olympus, Japan). Huh7 cells were seeded
on coverslips and cultured for 24 hours. Cells were
incubated with 1 μM Fluo-4, a Ca2+-specific dye, at
37°C for 20 minutes in Buffer Salt Saline (BSS) (2 mM
CaCl2, 5.5 mM D-glucose, 130 mM NaCl, 5.4 mM KCl,
20 mM HEPES pH = 7.4, 1 mM MgSO4) and then washed
three times before measuring the relative fluorescence
intensity. Cells were pretreated with various concen-
trations of 2-APB for 10 minutes, and then loaded
with 1 μM Fluo-4 for 20 minutes. After washing, cells
were maintained in calcium-free medium (5.5 mM
D-glucose, 130 mM NaCl, 5.4 mM KCl, 20 mM HEPES
(pH = 7.4), and 3 mM MgSO4) during the experimental
periods. The cells were then stimulated by adding BBP
(1 μM) after 1 minute. Data were analyzed with Cell-R
software.
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Huh7 cells were transfected with pEGFP-C1-AhR using
LT1 transfection reagent. After overnight transfection,
the cells were harvested and cultured on coverslips for
1 day. BBP (1 μM) was added to stimulate the cells be-
fore analysis by confocal microscopy. GFP intensity was
analyzed by FV10-ASW 3.0 software (Olympus, Japan).
Double immunogold transmission electron microscopy
Ultrathin sections of plastic-embedded cells were pre-
treated with 5% sodium metaperiodate (10 min) by
microwave fixation and processing. The grids were incu-
bated with an aliquot of IgG antibodies against AhR or
Gαq/11 (Santa Cruz Biotechnology, Santa Cruz, CA, USA)
followed by probing with secondary antimouse IgG gold
particles (6 nm) or anti rabbit IgG gold particles (20 nm),
respectively. After washing, the sections were blocked
by placing the grids on a drop of phosphate-buffered
saline (PBS) containing 1% ovalbumin and incubating for
15 minutes. Sections were then stained with uranyl acet-
ate and lead citrate for characterization by transmission
electron microscopy (H-700, Hitachi, Japan).
Fluorescence in situ hybridization
After treatment with BBP (1 μM) or DMSO for the con-
trol group, cells were fixed by adding fixation solution
(in 3.7% formaldehyde/PBS) at room temperature for
10 minutes. The cells were washed with PBS twice and
then permeabilized by adding 70% EtOH at 4°C for
1 hour. Cells were then washed in wash buffer (5 mL
20× saline-sodium citrate (SSC), 5 mL formamide, and
nuclease-free water to a final volume of 50 mL) for 5 mi-
nutes. Hybridization was performed by mixing 100 μL of
hybridization solution (1 g dextran sulfate, 20 × SSC, 1 mL
formamide for a 10% final concentration and nuclease-free
water to a final volume of 10 mL) with a specific AhR
probe (Stellaris™ FISH Probes, Biosearch Technology,
Novato, CA, USA) and incubating the mixture overnight
at 37°C. Cells were then stained with DAPI (1 μg/mL) for
5 minutes. After washing, a drop of mounting solution
was applied. The slides were then covered with the cell-
attached cover glasses and sealed with nail polish. Imaging
was performed by confocal microscopy.
RNA isolation and RT-PCR
Huh7 cells (3 × 105) were seeded in six-well plates, cul-
tured for 24 hours, and then incubated overnight in
serum free medium. The cells were then treated with
BBP (1 μM) for various times intervals. After stimula-
tion, cells were washed twice with PBS. Total RNA was
extracted with TRIzol (Invitrogen). The RNA (2 μg)
was applied to a Reverse Transcription System (Promega
Biosciences, San Luis Obispo, CA, USA) to synthesize
cDNA. The cDNA was then amplified by specific primers.The primer pairs were as follows: AhR, forward 5′-
TACTCTGCCGCCCAA ACTGG-3′, reverse 5′-GCTCT
GCAACCTCCGATTCC-3′; β-actin, forward 5′-CTCGC
TGTCCACCTTCCA-3′, reverse 5′-GCTGTCACCTT
CACCGTTC-3′. The PCR conditions were 95°C for 5 min,
and then 34 cycles of 95°C for 30 sec, 54°C for 30 sec, and
72°C for 1 min, and a final extension at 72°C for 10 min.
PCR products were separated on 2% agarose gels and visu-
alized using ethidium bromide.
siRNA and shRNA transfection
The following siRNAs were used: scrambled siRNA sense:
5′-GAUCAUACGUGCGAUCAGA-3′, antisense: 5′-UCU
GAUCGCACGUAUGAUC-3′ ; AhR siRNA (SASI_Hs02_
00332181, Sigma). The following shRNAs were obtained
from the National RNAi Core Facility at Academic
Sinica: control shRNA, 5′-TACAACAGCCACAACGT
CTAT-3′; AhR shRNA (1) (TRCN0000021255), AhR
shRNA (2) (TRCN00000245285), NF-κB shRNA (1) (TRCN
0000006518), and NF-κB shRNA (2) (TRCN0000006520).
Cells were transfected with siRNA (10 nM) or shRNA
(2 μg) using LT1 transfection reagent.
Immunoblot analysis
Whole cell extracts were prepared in RIPA lysis buffer
(Millipore, Temecula, CA, USA) containing 1× protease
inhibitor cocktail (Thermo Scientific, Waltham, MA,
USA). Protein concentrations were determined using a
BCA protein assay kit (Thermo Scientific, Rockford, IL,
USA). Equal amounts of protein (50 μg protein) were
resolved by sodium dodecyl sulfate-polyacaryamide gel
electrophoresis (SDS-PAGE), transferred onto a polyvi-
nylidene difluoride membrane, and blocked with 5%
nonfat dry milk for 1 hour at room temperature. After
blocking, the membrane was incubated overnight with
primary antibodies at 4°C and washed three times with
PBST. The horseradish peroxidase conjugated second-
ary antibodies (Santa Cruz Biotechnology) were incu-
bated for 1 hour at room temperature. The blots were
washed three times with PBST and then visualized with
an enhanced chemiluminescence kit (Thermo Scientific,
Rockford, IL, USA). The primary antibodies were as fol-
lows: AhR, Gαq/11, Gβ, PIP2, IP3R, and PI3K from Santa
Cruz Biotechnology (1:100); p44/42 MAPK (Erk1/2),
Akt, p-Akt (ser473), NFκB, LaminA/C, Histion H3 and
α-tubulin from Cell Signaling Technology (1:1000); COX-2
from Abcam (1:1000); β-actin from Sigma (1:1000).
Immunoprecipitation
After preclearing for 30 minutes with protein G agarose
(Millipore), antibodies specific for Gαq/11, Gβ, or PI3K
(1:100; Santa Cruz Biotechnology) or IgG (2 μg, Sigma-
Aldrich Co, St. Louis, MO, USA) were added before
overnight incubation at 4°C, followed by precipitation
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washed three times with RIPA lysis buffer, boiled in sam-
ple buffer, and the protein were resolved by 8% SDS-
PAGE before performing immunoblot analysis of the
indicated proteins.
Transwell migration and invasion assays
Cell migration assays were performed in 24-well in-
serts (8-μm pore size; BD Biosciences, Franklin Lakes,
NJ, USA) and cell invasion assays were performed in
24-well Matrigel™ Invasion inserts (8-μm pore size;
BD Biosciences, Franklin Lakes, NJ, USA). Cells (1 × 104)
in serum-free DMEM were seeded in the upper chamber
of the insert and DMEM containing 10% fetal bovine
serum was added to the lower chamber and followed
by incubation for 1 day (for migration) or 2 days (for
invasion). The medium and cells were then removed from
the top chamber using cotton swabs and PBS. The cells
were fixed with 4% paraformaldehyde for 30 minutes,
stained with a 0.5% crystal violet solution for 2 hours, and
counted under a microscopy.
Measurement of vascular endothelial growth factor
Huh7 cells were grown in 12-well plates and treated
with BBP for 1 day. After treatment, the cells were incu-
bated in fresh medium for 1 day. The media were then
collected and centrifuged at 1,000 rpm for 5 minutes to
remove cell debris. Vascular endothelial growth factor
(VEGF) levels in the conditioned medium were mea-
sured with an enzymed-linked immunosorbent assay
(ELISA) kit (R&D System, Minneapolis, MN, USA).
Angiogenesis tube formation assay
HUVEC (2 × 104 cells/mL) were seeded in a 48-well
plate pre-coated with Matrigel (BD Biosciences, San
Jose, CA, USA). After Huh7 cell-conditioned medium
was added to a final volume of 20%, the cells were cul-
tured for 16 hours, stained with calcium-AM (Invitrogen),
and visualized under a fluorescence microscope (Olympus).
Total tube lengths were measured by MetaMorph soft-
ware (Leica)
Animals
Male 6-week-old nude mice (BALB/cA-nu nu/nu) were
purchased from the National Science Council Animal
Center (Taiwan). All animal experiments were performed
according to a protocol approved by the Institutional
Animal Care and Use Committee of Kaohsiung Medical
University Hospital (IACUC Approval No: 101060).
In vivo tumor xenograft experiments
Huh7 cells were stably transfected with infrared fluores-
cent protein [20]. Briefly, 293 T cells were transfected
with pCMV-ΔR8.91, pMD.G, and pLKO AS3-reportergene using LT1 transfection reagent for 3 days, and the
supernatant (lentivirus-containing medium) was col-
lected the next day. Huh7 cells (2 × 105) were seeded into
six-well plates and incubated for 1 day. The lentivirus-
containing medium (200 μL) was mixed with 800 μL
of DMEM containing 8 μg/mL polybrene and added
to each well, and the cells were incubated for 1 day.
A stable clone was selected by puromycin treatment
(2 μg/mL) for 14 days. The cells were incubated with
25 μΜ biliverdin overnight and then purified Huh7-IFP
cells by flow cytometry. The hepatocellular carcinoma
model of direct intrahepatic injection was performed
according to a previous study [21] with some modifica-
tions. After a small incision was made in nude mice to
access the liver, Huh7-IFP cells (1 × 106) suspended in
PBS were slowly injected into the upper left lobe of the
liver using a 28-gauge needle. A transparent bleb of
cells was formed through the liver capsule after injec-
tion. To prevent bleeding, a small piece of sterile gauze
was placed, and light pressure was applied on the injec-
tion site. After implantation, the mice were placed
on a heating pad or below a heating lamp until fully
active. The mice were randomly divided into two groups
(vehicle or BBP treatment), 18 mice of each. After
3 days, BBP (500 mg/kg) was administered by intra-
peritoneal (i.p.) injection every 2 days. Previous studies
have reported that administration of BBP by i.p. at a
dose of 800 mg/kg for 24 weeks results in no signifi-
cant toxic effects [11,22], which is a higher dose than
that used in this study. Tumor growth was detected
by injecting biliverdin (250 nM) into the tail vein
30 minutes before imaging. After 1 month, the mice
were sacrificed and the organs (liver, lungs, kidneys,
and spleen) were removed and viewed with an Ultra Sensi-
tive Molecular Imaging System (Berthold Technology).
The numbers of the organs (lung, kidneys, spleen) that
expressed fluorescence, considered as metastasis positive
organs were determined.
Immunohistochemistry
Liver tissues were fixed with 4% paraformaldehyde,
embedded in paraffin, and cut into 4-μm thick sec-
tions. The sections were deparaffinized in xylene and
rehydrated with a graded series of ethanol/water solu-
tions (100% and 95% ethanol) and then water washes.
The sections were treated with 10 mM citrate buffer
at 95°C to retrieve antigens and blocked with 5% bo-
vine serum albumin. Primary antibodies against PI3K
(1:100; Santa Cruz Biotechnology) and NF-κB (1:200;
Cell Signaling) were applied to the sections at 4°C
overnight, and then the sections were incubated with
secondary antibodies and 3,3’-diaminobenzidine. Inten-
sities of PI3K and NF-κB staining were analyzed by Tissue
Quest software (Tissue Genomics)
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Huh7 cells (3 × 106) were suspended in 150 μL PBS,
mixed with 50 μL Matrigel (BD Biosciences), and injected
into the flanks of nude mice. BBP (1 μM) was added to
the cell suspensions of the treatment groups. After
21 days, the Matrigel plugs were removed. Hemoglobin
levels were determined by Drabkin reagent (Sigma), and
protein concentrations were normalized to measure blood
vessel formation.
Statistical analysis
Statistical significance was established using the Student’s
t-test. A p-value of < 0.05 was considered statistically
significant.
Results
BBP induced AhR expression
The effect of BBP on AhR mRNA expression was exam-
ined by RT-PCR. BBP transiently increased AhR mRNA
expression until it reached its highest level at 15 minutes
after treatment (Figure 1A). Next, we examined the
RNA level using a specific AhR mRNA probe. As a re-
sult, AhR mRNA expression was increased at 15 minutes
after BBP teratment, which was comparable with the
RT-PCR results (Figure 1B). Immunoblot analysis of the
effect of BBP on AhR expression showed that BBPFigure 1 BBP activates AhR mRNA and protein expression. (A) Huh7 c
analyzed by RT-PCR at the indicated time points. The agarose gel image is
by densitometry and is the mean of three independent experiments. Each va
The asterisks indicate a significant difference expression relative to the level at
treated with BBP (1 μM) or DMSO as the control group for 15 minutes, and th
in situ hybridization. Imaging was performed by confocal microscopy. (C) Huh
by immunoblotting at the indicated time.stimulated AhR expression in a time-dependent manner
(Figure 1C).
BBP activates AhR at the cell membrane, which interacts
with G proteins
To investigate whether AhR can be activated at the cell
membrane by BBP, Huh7 cells were transfected with
pEGFP-C1 as a plasmid control or pEGFP-C1-AhR treated
with DMSO as a viechle control or BBP, and then ana-
lyzed by TIRF microscopy. AhR-GFP expression peaked
at 2 minutes after BBP treatment (Figure 2A). Analysis
of AhR movement in Huh7 cells showed that AhR expres-
sion near the membrane increased in a time-dependent
manner. The experiment was performed by confocal mi-
croscopy and analyzed by FlowView 3.0 (Olympus, Japan)
(Figure 2B). Stimulation of both Gαq/11and Gβ expression
by BBP was analyzed by immunoblotting (Figure 2C).
Double immunogold transmission electron microscopy
and immunoprecipitation (Figure 2D, 2E) further showed
an interaction between AhR and G proteins. The action
of AhR was notably nongenomic. To investigate whether
the G-protein signaling induced by BBP was AhR
dependent, we knocked down AhR using an AhR shRNA.
The results showed that BBP-induced Gαq/11 and Gβ
expression was suppressed by transfection of the AhR
shRNA (Figure 2F).ells were treated with BBP (1 μM), and mRNA expression of AhR was
the expression of AhR mRNA. Each values in the graph was obtained
lue in the graph is the mean ± SD from three independent experiments.
0 minute, as analyzed by Student’s t-test (p < 0.05). (B) Huh7 cells were
en AhR mRNA was stained by fluorescence (carboxyfluorescein, FAM)
7 cells were treated with BBP (1 μM), and then AhR levels were analyzed
Figure 2 BBP activates AhR at the cell membrane, which interacts with G proteins. (A) Huh7 cells were transfected with pEGFP-C1-AhR or
pEGFP-C1 as a plasmid control. Cells were stimulated by adding DMSO or BBP (1 μM) and then analyzed by real-time TIRF microscopy. Scale bars:
10 μm. The left panel shows Huh7 cells transfected with the pEGFP-C1 plasmid control treated with DMSO (upper) or BBP (lower). The middle
panel shows Huh7 cells transfected with pEGFP-C1-AhR and then treated with DMSO (upper) or BBP (lower). The increased intensity of GFP
fluorescence indicates AhR expression at the cell membrane, which was induced by BBP. The right panel shows the GFP intensity analyzed by
Axio Vision Rel 4.8 software. (B) Huh7 cells were transfected with pEGFP-C1-AhR and then stimulated with BBP (1 μM) before analyzed by real-time
confocal microscopy (upper panel), Scale bars: 10 μm. The GFP intensity was analyzed by FV10-ASW 2.1 software (Olympus) (lower panel). (C) Expression
of Gαq/11 and Gβ proteins after BBP treatment for the indicated time was detected by immunoblotting. β-actin was used as an internal control.
(D) Interaction of AhR with Gαq/11 at the cell membrane after treatment with BBP (1 μM) was imaged by double immunogold electron microscopy.
Black arrows indicate Gαq/11, and the white arrows indicate AhR. The localization of G protein and AhR protein are shown. (upper left panel) shows
the untreatment group and (Lower left, Right left panel) indicated BBP treatment groups. Scale bars: 500 nm. CM, cell membrane; N, nucleus.
(E) Huh7 cells after 30 minutes of treatment with BBP (1 μM) or DMSO as the control. The interaction of AhR with Gαq/11 and Gβ was detected
by immunoprecipitation (IP) followed by immunoblot analysis. The IgG were used cell lysates mixed with control and BBP treatment group.
Normal rabbit IgG were used as negative control. (F) Huh7 cells were transfected with two different AhR shRNAs as described the Methods or
a control shRNA. After treatment with or without BBP (1 μM), AhR, Gαq/11, and Gβ levels were measured by immunoblotting. β-actin was used
as an internal control.
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Downstream signaling triggered by Gαq/11 was measured
by immunoblot analysis of Gαq/11, PIP2 and IP3R levels.
A decrease in PIP2 and an increase in IP3R indicated
cleavage of PIP2 to IP3, followed by activation of IP3R
(Figure 3A) [23]. The calcium response to BBP was then
analyzed with a live-cell calcium imaging system that
showed a sharp signal immediately after BBP addition
(Figure 3B). To determine whether the calcium was
derived from external or internal stores, calcium-freemedium was used in a second round of experiments.
As a result, calcium release was quickly stimulated
by addition of BBP, presumably from internal stores
(Figure 3C). The results were then confirmed using 2-APB,
an IP3R inhibitor. 2-APB inhibited the internal release of
calcium in a dose-dependent manner (Figure 3D). Ex-
pression of COX-2 was activated by BBP and inhibited
by 2-APB (Figure 3E, 3F). These results suggest that
BBP promotes COX-2 expression via AhR/Gαq/11/calcium
signaling.
Figure 3 AhR triggers Gαq/11/calcium/COX-2 signaling. (A) BBP induced a reduction in the level of PIP2 and activation of IP3R via Gαq/11. After
Huh7 cells treated with BBP (1 μM), protein levels were analyzed by immunoblotting at the indicated time points. (B) Real-time imaging of calcium
was performed by Cell-R microscopy. The experiment was performed in BSS medium. (C) Elevated intracellular calcium was induced by BBP treatment.
The experiment was performed with a calcium free medium. The arrows indicate the time points of BBP (1 μM) addition (1 minute after the experiment
started). The fluorescence intensity (Y-axis) indicates the relative calcium levels. (D) Huh7 cells in calcium-free medium were pretreated with various
concentrations of 2-APB for 30 minutes before stimulation with BBP (1 μM). Internal calcium release was inhibited by 2-APB in a dose-dependent
manner. The relative intensity of fluo-4 indicates the calcium levels: peak/baseline ratio of fluorescence intensity. Calcium-free medium was used for
each experimental interval. Each value in the graph is the mean ± SD of six replicate using at least ten cells. (E) COX-2 expression after BBP treatment
was measured by immunoblotting. Huh7 cells were treated with BBP (1 μM) for the indicated times before harvesting the cells. β-actin was used as an
internal control. (F) Huh7 cells were pretreated with 2-APB (20 μM) for 2 hours and followed by treated with BBP (1 μM). Control groups were treated
with DMSO. COX-2 levels were suppressed by 2-APB pretreatment.
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AhR/Gβ/PI3K/Akt/NF-κB signaling
Gβ protein activates PI3K by direct binding [24]. Immu-
noprecipitation was performed to examine the effect of
BBP treatment on interactions between Gβ protein and
PI3K (Figure 4A). The binding of Gβ protein to PI3K
was increased after BBP treatment. To further study the
downstream pathway triggered by Gβ activation, we ana-
lyzed PI3K enhancement and Akt phosphorylation by
immunoblotting. PI3K and Akt phosphorylation level
were increased after BBP treatment (Figure 4B). We also
found translocation of NF-κB into the nucleus (Figure 4C).
Treatment with a PI3K inhibitor (wortmannin) reduced
Akt phosphorylation (Figure 4D) and inhibited NF-κBtranslocation into the nucleus (Figure 4E). To further
confirm whether PI3K/Akt/ NF-κB activation is specif-
ically stimulated by BBP via AhR, we transfected Huh7
cells with two different AhR shRNAs. The increase of
PI3K and p-Akt (Figure 4F), and translocation of NF-κB
into the nucleus (Figure 4G) induced by BBP were inhib-
ited by transfection of the shRNAs. PI3K/Akt/NF-κB en-
hances cell migration and invasion [25]. Thus, we further
investigated the mechanisms of cell migration and inva-
sion which are induced by BBP. Huh7 cells were trans-
fected with two different AhR shRNAs, NF-κB shRNA,
or control shRNA for 48 hours, followed by preparation
of cell lysates. The protein levels of AhR and NF-κB
markedly decreased after transfection with AhR and
Figure 4 AhR triggers Gβ/PI3K/Akt/NF-κB signaling. (A) The PI3K and Gβ protein interaction was assessed by immunoprecipitation. Huh7 cells
were immunoprecipitated with antibodies against Gβ or PI3K. Normal IgG was used as a negative control. (B) Cells were treated with BBP (1 μM)
for various durations, and then PI3K and phosphorylation levels of Akt were determined by immunoblotting. (C) Nuclear and cytoplasmic fractions
of NF-κB were detected by immunoblotting. Lamin A/C and α-tubulin were used as internal markers for nuclear and cytoplasmic proteins, respectively.
Huh7 cells were pretreated with wortmannin (100 nM) and then treated with BBP (1 μM) for 2 hours. (D) The Akt phosphorylation levels were measured
and β-actin was used as an internal control. (E) The nuclear and cytoplasmic fractions of NF-κB were analyzed by immunoblotting. Huh7 cells were
transfected with two different shRNA and treated with BBP (1 μM) for 2 hours. (F) PI3K, p-Akt, Akt levels were measured by immunoblotting. β-actin
was used as an internal control. (G) The nuclear and cytoplasmic fractions of NF-κB were analyzed by immunoblotting. Histone H3 and α-tubulin
were used as internal markers for nuclear and cytoplasmic proteins, respectively.
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http://www.biomedcentral.com/1471-2407/14/556NF-κB shRNAs compared with those after transfection
with control shRNA (Figure 5A). To further study the ef-
fects of BBP on Huh7 cells migration and invasion, trans-
well migration and invasion assays were performed. AhR
and NF-κB shRNAs inhibited cell migration and invasion
induced by BBP (Figure 5B). These results suggest that
BBP promotes cell migration and invasion by activation
of AhR/Gβ/PI3K/Akt/NF-κB signaling.
BBP promotes in vivo metastasis
The mouse intrahepatic injection model was established
to examine tumor metastasis [26]. Huh7-IFP cells (1 × 106)
were suspended in 30 μL PBS and injected into the mouse
liver (At 3 days after of implantation, 500 mg/kg BBP was
administered by i.p. injection every 2 days. Weekly imaging
of the mice confirmed that the tumor sizes increased over
time (Figure 5C). The mice were sacrificed after 1 monthto compare tumor metastasis between control and BBP
treatment groups. The metastasis rates in the lungs, kid-
neys, and spleen were higher in the BBP treatment group
than those in the control group (Figure 5D), suggesting
that BBP promotes metastasis. Immunohistochemistry
showed that liver PI3K and NF-κB levels were significantly
higher in the treatment group than those in the control
group (Figure 5E).
BBP promotes angiogenesis in vitro and in vivo
To examine the effect of BBP on angiogenesis, the condi-
tioned medium of Huh7 cells that had been treated with
BBP was examined for its ability to induce the formation
of capillary-like structures by HUVEC (Figure 6A). The
levels of VEGF, which promotes angiogenesis [27], were
also measured in the conditioned medium (Figure 6A).
To explore the associated mechanisms, Huh7 cells were
Figure 5 Effects of BBP on cell migration and invasion in vitro and metastasis in vivo. (A) Huh7 cells were transfected with two different
AhR (top) and NF-κB (bottom) shRNA as described in the Methods, and then protein levels were detected by immunoblotting. (B) Transwell
migration and invasion assays. Huh7 cells transfected with control, AhR, or NF-κB shRNAs were seeded onto inserts, treated with or without BBP,
and allowed to migrate for 24 (migration) or 48 (invasion) hours. The numbers of migrating and invading cells were counted under a microscope.
Scale bars: 100 μm. (C) Tumor growth of intrahepatically injected Huh7-IFP cells in vehicle control and BBP treatment groups for the indicated times
of was detected by non-invasive imaging. (D) Numbers of other organs with metastasis of vehicle control or BBP treatment group (n = 18
for each group) after 4 weeks. (E) Immunohistochemical staining for PI3K and NF-κB in the tumor region of the mouse liver after treatment
of BBP for 4 weeks. Magnificantion, 40x. The intensity of PI3K and NF-κB staining was analyzed by Tissue Quest software. Data shown in panels B
and E are representative of three independent experiments. Each value is the mean ± SD of three independent experiments. The asterisks indicate a
significant difference between vehicle treated group and BBP treated groups, as analyzed by Student’s t-test (*p < 0.05; **p < 0.01).
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http://www.biomedcentral.com/1471-2407/14/556treated with the ERK inhibitor Pd98059 (Figure 6A) or
transfected with AhR siRNA (Figure 6B) before collection
of the medium. Analyses of the media showed that both
Pd98059 and AhR siRNA inhibited tube formation of
HUVEC and reduced VEGF induction after BBP treat-
ment. Moreover, we evaluated the phosphorylation levels
of ERK (Figure 6C). To further confirm whether activa-
tion of ERK was AhR dependent, we trasfected Huh7
cells with two different AhR shRNAs and the results
showed inhibition of the phosphorylation levels of ERK
induced by BBP (Figure 6D). The angiogenic effects of
BBP were then assessed in an in vivo Matrigel plug angio-
genesis assay model. Briefly, Huh7 cells were mixed with
Matrigel and injected into the flanks of nude mice. After
3 weeks, the mice were sacrificed, and hemoglobin levelsin the plug were measured. Hemoglobin levels in the
Matrigel plug treated with BBP were significantly higher
than those in the control group (Figure 6E).
Discussion
In this study, we provide evidence that phthalate pro-
motes hepatocellular carcinoma progression through a
nongenomic AhR pathway. Rodent studies of the car-
cinogenesis of phthalate have yielded substantial data
[5]. Some human epidemiological studies have also shown
a cancer risk associated with phthalate exposure, including
respiratory cancer [28], pancreatic cancer [29], and breast
cancer [30]. However, the mechanisms of carcinogenesis
have been rarely explored for phthalate. To further in-
vestigate such mechanisms, we treated hepatocellular
Figure 6 Effects of BBP on angiogenesis in vitro and in vivo. Effect of Huh7 cell-conditioned medium on HUVEC tube formation. Huh7
cells were pretreated with or without Pd98059 (A) or transfected with scrambled siRNA or AhR siRNA (B) followed by BBP treatment, and the
conditioned medium was then collected from each culture dish. HUVEC were seeded in BioCoated angiogenesis plates, treated with 20%
Huh7-conditioned medium, and incubated for 16 hours. HUVEC were imaged after staining with Calcein-AM. Total tube lengths were analyzed
by MetaMorph software. Scale bars: 200 μm. VEGF levels in the conditioned media were measured by ELISA. (C) Huh7 cells were treated with
BBP for the indicated times. p-ERK and ERK levels were measured by immunoblotting. β-actin used as an internal control. (D) Huh7 cells were
transfected with two different Huh7 shRNAs and then treated with BBP (1 μM) for 15 minutes. p-ERK, ERK levels were evaluated by immunoblotting.
(E) Huh7 cells were mixed with Matrigel with or without BBP (1 μM), injected into the flanks of nude mice, and allowed to grow for 21 days.
Hemoglobin levels in Matrigel plugs, which indicated blood vessel formation, were measured by Drabkin reagent kit 525. Each value is the
mean ± SD of three independent experiments. The asterisks indicate a significant difference between control and test groups, as analyzed by Student’s
t-test (*p < 0.05; **p < 0.01).
Tsai et al. BMC Cancer 2014, 14:556 Page 10 of 13
http://www.biomedcentral.com/1471-2407/14/556carcinoma cell lines, Huh7, HepG2 and PLC cells with
BBP (1 μM). All cell lines showed the activation of AhR
after treatment (Additional file 1: Figure S1). We then
tested the functions of cells treated with BBP including
migration, invasion and angiogenesis. We found that BBP
induced migration of Huh7 and PLC cell lines. In addition,
BBP induced invasion and angiogenesis of Huh7 cells
(Additional file 2: Figure S2). These results may be due to
the higher constitutional level of AhR in Huh7 than in that
in PLC cells (Additional file 2: Figure S2D). HepG2 cells
are not appropriate for further animal studies for non-
tumorigenic properties in immunosuppressed mice [31].
Therefore, we further investigated the mechanism induced
by BBP in Huh7 cells. We used Huh7 cells in the in vivostudy, and clarified the effect of BBP induced metastasis
and angiogenesis in vivo.
Our current study showed that BBP treatment induces
a nongenomic function through AhR and further clari-
fied that AhR translocates to the membrane and subse-
quently activates G-protein signaling. Our investigation
is consistent with a previous report in the nongenomic
AhR mechanism induced by TCDD, showing that TCDD
rapidly increases calcium concentrations and induces
COX-2 expression in U937 macrophages, mouse MMDD1
macula densa cells, and MCF10 cells [14,17]. We believe
that the nongenomic action explains why cells elict fast in-
flammatory responses to the environmental pollutant
TCDD and the endocrine disrupting agent, phthalate. After
Figure 7 Proposed signaling pathway of Huh7 cells treated
with BBP (see the text for details).
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http://www.biomedcentral.com/1471-2407/14/556BBP treatment, the AhR mRNA levels were unregulated.
Certain molecular such as NF-κB, interleukin (IL)-27 and
IL-6 were investigated that can regulate AhR expression
[32-34]. However, the mechanism of BBP induced AhR
mRNA upregulation has remained unclear. Subsequently
the nongenomic action triggers the cell signal pathways
and affects the cell function. A previous study showed
that by interacting with AhR-interacting protein, Gα13
destabilized AhR via the ubiquitin-proteasome pathway
[18]. Polycyclic aromatic hydrocarbons (PAH), which is
the AhR ligand, induceds expression of AhR target
genes through directed bind to G protein coupled re-
ceptor and activates G protein/ cAMP/ 1,4,5-trisphosphate
(IP3) pathway, which results in calcium induction [35].
The current study further confirmed that AhR positively
regulates G proteins, including Gαq/11 and Gβ through
nongenomic mechnissams. To our knowledge, the present
study is the first investigation to elicit that phthalate acti-
vates AhR through a non-genomic mechanism that in-
volving G protein signaling. Importantly, we provide
evidence that the tumor progression, including migra-
tion, invasion and angiogenesis were regulated by this
phthalate-induced signaling pathways.
Immortalized fibroblasts from Ahr−/− mice demon-
strate a lower tumorigenic potential because of dimin-
ished cell motility and responses to angiogenic factors
[36]. Overexpression of AhR promotes the development
of malignant cellular phenotypes and also increases their
cell proliferation rate, motility, migration, and confers
the ability to invade Matrigel in immortalized normal
human mammary epithelial cells [37]. Activation of AhR
is functionally connected to a signaling cascade that dra-
matically alters plasticity and increases motility in MCF-7
cells [38].
Angiogenesis contributes to tumor metastasis [39]. It
has been reported AhR regulates both in vitro and
in vivo angiogenesis. AhR−/− endothelial cells fail to form
tube-like structures, and impaired angiogenesis limits
tumor xenograft growth in AhR null mice [40]. The
current study showed that BBP promoted angiogenesis
through nongenomic AhR mechanisms, and VEGF ex-
pression was increased by ERK1/2 phosphorylation. This
finding is consistent with an earlier study showing that
an ER-dependent mechanism involving activation of
MEK, p38 kinase, and PI3K pathways by xenoestrogens
up-regulates VEGF expression in breast cancer cells [41].
However, our current study is the first to show that BBP
increases both in vitro and in vivo angiogenesis of liver
cancer.
Previous reports have revealed that phthalates promote
cancer cell migration, invasion and epithelial-mesenchymal
transition, which may explain the cancer progression
observed in both ER-dependent and AhR-dependent
pathways [10,42-44]. Several reports have shown thatAhR regulates cell migration, invasion and plasticity, all
of which contribute to tumor progression [10,36,45-47].
Our study showed that BBP promoted cell migration and
invasion through the AhR/Gβ/PI3K/Akt/NF-κB pathway
in hepatocellular carcinoma cells. These indicate phthal-
ate stimulates various cell signaling pathways of cancer
cell migration and invasion. Our data showed metastasis
can be promoted by phthatlate in vitro and in an animal
model in vivo. This is a phenomenon need to be ad-
dressed as metastasis is the key for the prognosis of can-
cer treatment.
Overexpression of COX-2 occurs in many pre-malignant,
malignant, and metastatic cancers, including hepato-
cellular carcinoma. COX-2 regulates carcinogenesis by
regulating angiogenesis [48], suppressing the immune
response, and by inhibiting apoptosis, and tumor cell
invasion, and metastasis [49]. Our data suggest that BBP
may contribute to angiogenesis, tumor cell invasion and
metastasis by increasing COX-2 expression.
Conclusions
Taking these results together, we propose a signaling
pathway for BBP stimulated hepatocellular carcinoma
progression (Figure 7). BBP induces membrane trans-
location of AhR and the initial activation of COX-2
by AhR/Gαq/11 signaling. In addition, BBP promotes
angiogenesis via the AhR/ERK/VEGF pathway and cell
migration and invasion through AhR/Gβ/PI3K/Akt/NF-κB
signaling.
In conclusion, we revealed a nongenomic AhR mech-
anism that may account for the modulated progression
of liver cancer after phthalate exposure. Our results
imply that BBP has a promoting impact on hepatocellu-
lar carcinoma, and that phthalate should be avoided in
theses patients.
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Additional file 1: Figure S1. Effects of BBP on AhR expression of
hepatocellular carcinoma cell lines. Huh7, HepG2, and PLC cells were
treated with BBP (1 μM) for 24 hours and AhR protein levels were then
analyzed by immunoblotting. β-actin was used as an internal control.
Additional file 2: Figure S2. Effects of BBP on angiogenesis, migration
and invasion. (A) Effect of conditioned media from Huh7 and PLC cells
on HUVEC tube formation. After Huh7 and PLC cells were treated with
BBP (1 μM) for 1 day, the culture medium was changed to the fresh
medium and the cells were cultured for 1 day. Conditioned medium
was collected from each culture dish. HUVEC were treated with 20%
conditioned medium and incubated for 16 hours. HUVEC were imaged
after staining with Calcein-AM (top). Total tube lengths were determined
by MetaMorph software (bottom). Scale bar: 200 μm. The asterisks indicates
a significant difference between control and test groups, as analyzed by
Student’s t-test (*p < 0.05). (B) Transwell migration assay. (C) Transwell
invasion assay. Huh7 and PLC cells were seeded on inserts and treated
with BBP (1 μM). Scale bars: 100 μm. (D) Huh7 and PLC cells were
harvested to prepare whole cell lysates for AhR protein levels were
measured by immunoblotting, β-actin was used as an internal control.
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